Clinical Trials in the European Union - EMA
CLINICAL STUDY PROTOCOL
CTIS for sponsors - EMA
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
In-silico trial of intracranial flow diverters replicates and expands insights from conventional clinical trials | Nature Communications
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
RPA in Clinical Trials: 5 Ways RPA Innovates Medical Research
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Run-in bias in randomised trials: the case of COPD medications | European Respiratory Society
PDF) Randomized clinical trials with run-in periods: frequency, characteristics and reporting
PDF) Randomized clinical trials with run-in periods: frequency, characteristics and reporting
Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial | Nature Communications
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Randomised controlled trial of intravenous nafamostat mesylate in COVID pneumonitis: Phase 1b/2a experimental study to investigate safety, Pharmacokinetics and Pharmacodynamics - eBioMedicine
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial - The Lancet
study design. Notes: Throughout the run-in phase, all patients received... | Download Scientific Diagram
Run-in periods in clinical trials: What can we ACHIEVE? — NephJC
Results from clinical trial simulations evaluating the effect of run-in... | Download Scientific Diagram
Clinical Trials in the European Union - EMA
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer | NEJM
Analysis of clinical trial registry entry histories using the novel R package cthist | PLOS ONE
Flowchart of screening for randomized clinical trials and for run-in... | Download Scientific Diagram
